ALTAVERA Drug Patent Profile
✉ Email this page to a colleague
When do Altavera patents expire, and what generic alternatives are available?
Altavera is a drug marketed by Xiromed and is included in one NDA.
The generic ingredient in ALTAVERA is ethinyl estradiol; levonorgestrel. There are twenty-six drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; levonorgestrel profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ALTAVERA?
- What are the global sales for ALTAVERA?
- What is Average Wholesale Price for ALTAVERA?
Summary for ALTAVERA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 5 |
| Clinical Trials: | 1 |
| Patent Applications: | 277 |
| Drug Prices: | Drug price information for ALTAVERA |
| Drug Sales Revenues: | Drug sales revenues for ALTAVERA |
| DailyMed Link: | ALTAVERA at DailyMed |
Recent Clinical Trials for ALTAVERA
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of California, Davis | Phase 4 |
| Washington University School of Medicine | Phase 4 |
US Patents and Regulatory Information for ALTAVERA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Xiromed | ALTAVERA | ethinyl estradiol; levonorgestrel | TABLET;ORAL-28 | 079102-001 | Aug 3, 2010 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
